Beyond dyssynchrony in cardiac resynchronisation therapy

Heart

Volumn 94, Issue 8, 2008, Pages 991-994

  Chung, R ^a   Sutton, R ^b   Henein, M Y ^c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOPULMONARY BYPASS; DEVICE THERAPY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM; HUMAN; M MODE ECHOCARDIOGRAPHY; PLACEBO EFFECT; PRIORITY JOURNAL; REVIEW; SYSTOLIC DYSFUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE;

CARDIAC PACING, ARTIFICIAL; HEART FAILURE; HUMANS; PATIENT SELECTION; TREATMENT FAILURE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 47849120479     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.132373     Document Type: Review

References (46)

1. Calvert MJ, Freemantle N, Yao G, et al. CARE-HF Investigators. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J 2005;26:2681-8.
2. Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
3. Duncan A, Wait D, Gibson D, et al. MUSTIC (Multisite stimulation in cardiomyopathies trial). Left ventricular remodelling and haemodynamic of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: substudy of the MUSTIC (multisite stimulation in cardiomyopathies) trial. Eur Heart J 2003;24:430-41.
4. Salukhe TV, Dimopoulos K, Francis D. Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC. Int J Cardiol 2004;93:101-3.
5. Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834-40.
6. Shapiro E, Marier DL, St John Sutton MG, et al. Regional non-uniformity of wall dynamics in normal left ventricle. Br Heart J 1981;45:264-70.
7. Wiggers CJ. The interpretation of the intraventricular pressure curve on the basis of rapidly summated fractionate contractions. Am J Physiol 1927;80:1-11.
8. Shaver JA, Nadolny RA, O'Toole JD, et al. Sound pressure correlates of the second heart sound. An intracardiac sound study. Circulation 1974;49:316-25.
9. Xiao HB, Roy C, Gibson DG. Nature of ventricular activation in patients with dilated cardiomyopathy: evidence for bilateral bundle branch block. Br Heart J 1994;72:167-74.
10. Gibson DG, Prewitt TA, Brown DJ. Analysis of left ventricular wall movement during isovolumic relaxation and its relation to coronary artery disease. Br Heart J 1976;38:1010-9.
11. Fung JWH, Yu CM, Yip G, et al. Variable left ventricular activation pattern in patients with heart failure and left bundle branch block. Heart 2004;90:17-9.
12. Yu CM, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003;89:54-60.
13. Auricchio A, Yu CM. Beyond the measurement of QRS complex toward mechanical dyssynchrony: cardiac resynchronisation therapy in heart failure patients with a normal QRS duration. Heart 2004;90:479-81.
14. Sanderson JE. QRS duration alone to select patients for cardiac resynchronisation therapy: flying in the face of evidence? Reply. Eur Heart J 2006;27:3075.
15. Bleeker G, Yu CM, Nihoyannopoulos P, et al. Optimal use of echocardiography in cardiac resynchronisation therapy. Heart 2007;93:1339-50.
16. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615-22.
17. Henein MY, Gibson DG. Suppression of left ventricular early diastolic filling by long axis asynchrony. Br Heart J 1995;73:151-7.
18. Duncan AM, Lim E, Gibson DG, et al. Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization. Eur Heart J 2006;27:2426-32.
19. Salukhe TV, Morgan M, Dimopoulos K, et al. Instantaneous effects of resynchronization therapy on exercise performance in heart failure patients: the mechanistic role and predictive power of total isovolumic time. Heart 2008;94 : 59-64..
20. Van de Veire NR, Bleeker GB, De Sutter J, et al. Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy. Heart 2007;93:1034-9.
21. Yu CM, Zhang Q, Fung JW, et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronisation therapy by tissue synchronization imaging. J Am Coll Cardiol 2005;45:677-84.
22. Kawaguchi M, Murabayashi T, Fetics BJ, et al. Quantitation of basal dyssynchrony and acute resynchronization from left or biventricular pacing by novel echo-contrast variability imaging. J Am Coll Cardiol 2002;39:2052-8.
23. Sutherland GR, Kukulski T, Kvitting JE, et al. Quantitation of left-ventricular asynergy by cardiac ultrasound. Am J Cardiol 2000;86:4-9G.
24. Becker M, Franke A, Breithardt OA, et al. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study. Heart 2007;93:1197-203.
25. Zhang Q, Yu CM, Fung JW, et al. Assessment of the effect of cardiac resynchronization therapy on intraventricular mechanical synchronicity by regional volumetric changes. Am J Cardiol 2005;95:126-9.
26. Kapetanakis S, Kearney MT, Siva A, et al. Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation 2005;112:992- 1000.
27. Chung R, Li W, Henein MY. Measurement of basal ventricular asynchrony by real-time 3D long axis echocardiography. Eur J Echo 2006;7:S158.
28. Helm RH, Byrne M, Helm PA, et al. Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Circulation 2007;115:953-61.
29. Fung JW, Chan JY, Yip GW, et al. Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy. Heart 2007;93:432-7.
30. Jin XY, Gibson DG, Pepper JR. Early changes in regional and global left ventricular function after aortic valve replacement. Comparison of crystalloid, cold blood, and warm blood cardioplegias. Circulation 1995;92:11155-62.
31. Mehra MR, Greenberg BH. Cardiac resynchronization therapy: caveat medicus! J Am Coll Cardiol 2004;43:1145-8.
32. Sanderson JE. Assessment of ventricular dyssynchrony: global or regional function? Eur Heart J 2006;27:2380-1.
33. Cleland JG, Daubert JC, Erdmann E, et al. CARE-HF study Steering Committee and Investigators. Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail 2005;7:205-14.
34. Nikolic S, Yellin EL, Tamura K, et al. Passive properties of canine left ventricle: diastolic stiffness and restoring forces. Circ Res 1988;62:1210-22.
35. Salukhe TV, Francis DP, Clague JR, et al. Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling pattern. Int J Cardiol 2005;100:5-12.
36. Henein MY, Amadi A, O'Sullivan C, et al. ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease. Heart 1996;76:326-31.
37. Duncan AM, Francis DP, Gibson DG, et al. Limitation of exercise tolerance in chronic heart failure: distinct effects of left bundle-branch block and coronary artery disease. J Am Coll Cardiol 2004;43:1524-31.
38. Brunner-La Rocca HP, Capraro J, et al. Compliance by referring physicians with recommendations on heart failure therapy from a tertiary center. J Cardiovasc Pharmacol Ther 2006;11:85-92.
39. Drechsler K, Dietz R, Klein H, et al. Euro heart failure survey. Medical treatment not in line with current guidelines. Z Kardiol 2005;94:510-5.
40. Komajda M, Lapuerta P, Hermans N, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005;26:1653-9.
41. Pont LG, Sturkenboom MC, van Gilst WH, et al. Trends in prescribing for hear: failure in Dutch primary care from 1996 to 2000. Pharmacoepidemiol Drug Saf 2003;12:327-34.
42. Komajda M, Follath F, Swedberg K, et al. For the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment. Eur Heart J 2003;24:464-74.
43. Freemantle N, Tharmanathan P, Calvert MJ, et al. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis. Eur J Heart Fail 2006;8:433-40.
44. Linde C. Results of the predictors of response to CRT (PROSPECT) trial. European Society of Cardiology Congress Vienna 2007. Available at http://www.escardio.org/knowledge/congresses/congressreports/2007/hl-ctu/ 3222-linde-hotline2.htm (accessed 6 May 2008).
45. Duncan AM, Lim E, Gibson DG, et al. Effect of dobutamine stress on left ventricular filling in ischemic dilated cardiomyopathy: pathophysiology and prognostic implications. J Am Coll Cardiol 2005;46:488-96.
46. Henein MY, O'Sullivan CA, Coats AJ, et al. Angiotensin-Converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease. J Am Coll Cardiol 1998;32:1187-93.